Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × veliparib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Glioblastoma 2 Thrombocythemia, Essential 1 Testicular Neoplasms 1 Renal Insufficiency 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lung Neoplasms 1 Liver Failure 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Rituximab 21 Cyclophosphamide 11 Lenalidomide 9 zanubrutinib 7 venetoclax 6 orelabrutinib 6 obinutuzumab 6 fludarabine 6 pirtobrutinib 4 fludarabine phosphate 4 Vincristine 4 Prednisone 4 Magnetic Resonance Spectroscopy 4 CT-P10 4 Bendamustine Hydrochloride 4 ibrutinib 3 Whole-Body Irradiation 3 Specimen Handling 3 Doxorubicin 3 acalabrutinib 2 Radiation 2 Mycophenolic Acid 2 Maintenance 2 Cyclosporine 2 Biopsy 2 voruciclib 1 umbralisib 1 treosulfan 1 tislelizumab 1 tafasitamab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡